Covid-19 Impact on Global Adipose Tissue-derived Stem Cell Therapy Market Size, Status and Forecast 2020-2026

July 2020 | 129 pages | ID: CC12AFB98F5BEN
QYResearch

Abstracts

Adipose Tissue-derived Stem Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adipose Tissue-derived Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Adipose Tissue-derived Stem Cell Therapy market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Adipose Tissue-derived Stem Cell Therapy industry.
The key players covered in this study

• AlloCure
• Antria
• Celgene Corporation
• Cellleris
• Corestem
• Cytori Therapeutics
• Intrexon
• Mesoblast
• Pluristem Therapeutics
• Tissue Genesis
• BioRestorative Therapies
• Celltex Therapeutics Corporation
• iXCells Biotechnologies
• Pluristem Therapeutics
• Cyagen
• Lonza

Market segment by Type, the product can be split into

• Autologous Stem Cells
• Allogeneic Stem Cells

Market segment by Application, split into

• Therapeutic Application
• Research Application

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Adipose Tissue-derived Stem Cell Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Adipose Tissue-derived Stem Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Adipose Tissue-derived Stem Cell Therapy are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adipose Tissue-derived Stem Cell Therapy Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Autologous Stem Cells
  1.4.3 Allogeneic Stem Cells
1.5 Market by Application
  1.5.1 Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Therapeutic Application
  1.5.3 Research Application
1.6 Coronavirus Disease 2019 (Covid-19): Adipose Tissue-derived Stem Cell Therapy Industry Impact
  1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.6.2 Covid-19 Impact: Commodity Prices Indices
  1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Covid-19 Implications on Global Adipose Tissue-derived Stem Cell Therapy Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Adipose Tissue-derived Stem Cell Therapy Growth Trends by Regions
  2.2.1 Adipose Tissue-derived Stem Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Adipose Tissue-derived Stem Cell Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Adipose Tissue-derived Stem Cell Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Adipose Tissue-derived Stem Cell Therapy Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Adipose Tissue-derived Stem Cell Therapy Players by Market Size
  3.1.1 Global Top Adipose Tissue-derived Stem Cell Therapy Players by Revenue (2015-2020)
  3.1.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Adipose Tissue-derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adipose Tissue-derived Stem Cell Therapy Market Concentration Ratio
  3.2.1 Global Adipose Tissue-derived Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Adipose Tissue-derived Stem Cell Therapy Revenue in 2019
3.3 Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Area Served
3.4 Key Players Adipose Tissue-derived Stem Cell Therapy Product Solution and Service
3.5 Date of Enter into Adipose Tissue-derived Stem Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Adipose Tissue-derived Stem Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020)
5.2 Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA IMPACT OF COVID-19

6.1 North America Adipose Tissue-derived Stem Cell Therapy Market Size (2015-2020)
6.2 Adipose Tissue-derived Stem Cell Therapy Key Players in North America (2019-2020)
6.3 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020)
6.4 North America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020)

7 EUROPE IMPACT OF COVID-19

7.1 Europe Adipose Tissue-derived Stem Cell Therapy Market Size (2015-2020)
7.2 Adipose Tissue-derived Stem Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020)

8 CHINA IMPACT OF COVID-19

8.1 China Adipose Tissue-derived Stem Cell Therapy Market Size (2015-2020)
8.2 Adipose Tissue-derived Stem Cell Therapy Key Players in China (2019-2020)
8.3 China Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020)
8.4 China Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020)

9 JAPAN IMPACT OF COVID-19

9.1 Japan Adipose Tissue-derived Stem Cell Therapy Market Size (2015-2020)
9.2 Adipose Tissue-derived Stem Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA IMPACT OF COVID-19

10.1 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size (2015-2020)
10.2 Adipose Tissue-derived Stem Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020)

11 INDIA IMPACT OF COVID-19

11.1 India Adipose Tissue-derived Stem Cell Therapy Market Size (2015-2020)
11.2 Adipose Tissue-derived Stem Cell Therapy Key Players in India (2019-2020)
11.3 India Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020)
11.4 India Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19

12.1 Central & South America Adipose Tissue-derived Stem Cell Therapy Market Size (2015-2020)
12.2 Adipose Tissue-derived Stem Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 AlloCure
  13.1.1 AlloCure Company Details
  13.1.2 AlloCure Business Overview and Its Total Revenue
  13.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Introduction
  13.1.4 AlloCure Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020))
  13.1.5 AlloCure Recent Development and Reaction to COVID-19
13.2 Antria
  13.2.1 Antria Company Details
  13.2.2 Antria Business Overview and Its Total Revenue
  13.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Introduction
  13.2.4 Antria Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  13.2.5 Antria Recent Development and Reaction to COVID-19
13.3 Celgene Corporation
  13.3.1 Celgene Corporation Company Details
  13.3.2 Celgene Corporation Business Overview and Its Total Revenue
  13.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Introduction
  13.3.4 Celgene Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  13.3.5 Celgene Corporation Recent Development and Reaction to COVID-19
13.4 Cellleris
  13.4.1 Cellleris Company Details
  13.4.2 Cellleris Business Overview and Its Total Revenue
  13.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Introduction
  13.4.4 Cellleris Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  13.4.5 Cellleris Recent Development and Reaction to COVID-19
13.5 Corestem
  13.5.1 Corestem Company Details
  13.5.2 Corestem Business Overview and Its Total Revenue
  13.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Introduction
  13.5.4 Corestem Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  13.5.5 Corestem Recent Development and Reaction to COVID-19
13.6 Cytori Therapeutics
  13.6.1 Cytori Therapeutics Company Details
  13.6.2 Cytori Therapeutics Business Overview and Its Total Revenue
  13.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
  13.6.4 Cytori Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  13.6.5 Cytori Therapeutics Recent Development and Reaction to COVID-19
13.7 Intrexon
  13.7.1 Intrexon Company Details
  13.7.2 Intrexon Business Overview and Its Total Revenue
  13.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Introduction
  13.7.4 Intrexon Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  13.7.5 Intrexon Recent Development and Reaction to COVID-19
13.8 Mesoblast
  13.8.1 Mesoblast Company Details
  13.8.2 Mesoblast Business Overview and Its Total Revenue
  13.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Introduction
  13.8.4 Mesoblast Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  13.8.5 Mesoblast Recent Development and Reaction to COVID-19
13.9 Pluristem Therapeutics
  13.9.1 Pluristem Therapeutics Company Details
  13.9.2 Pluristem Therapeutics Business Overview and Its Total Revenue
  13.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
  13.9.4 Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  13.9.5 Pluristem Therapeutics Recent Development and Reaction to COVID-19
13.10 Tissue Genesis
  13.10.1 Tissue Genesis Company Details
  13.10.2 Tissue Genesis Business Overview and Its Total Revenue
  13.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Introduction
  13.10.4 Tissue Genesis Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  13.10.5 Tissue Genesis Recent Development and Reaction to COVID-19
13.11 BioRestorative Therapies
  10.11.1 BioRestorative Therapies Company Details
  10.11.2 BioRestorative Therapies Business Overview and Its Total Revenue
  10.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Introduction
  10.11.4 BioRestorative Therapies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  10.11.5 BioRestorative Therapies Recent Development and Reaction to COVID-19
13.12 Celltex Therapeutics Corporation
  10.12.1 Celltex Therapeutics Corporation Company Details
  10.12.2 Celltex Therapeutics Corporation Business Overview and Its Total Revenue
  10.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Introduction
  10.12.4 Celltex Therapeutics Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  10.12.5 Celltex Therapeutics Corporation Recent Development and Reaction to COVID-19
13.13 iXCells Biotechnologies
  10.13.1 iXCells Biotechnologies Company Details
  10.13.2 iXCells Biotechnologies Business Overview and Its Total Revenue
  10.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Introduction
  10.13.4 iXCells Biotechnologies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  10.13.5 iXCells Biotechnologies Recent Development and Reaction to COVID-19
13.14 Pluristem Therapeutics
  10.14.1 Pluristem Therapeutics Company Details
  10.14.2 Pluristem Therapeutics Business Overview and Its Total Revenue
  10.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Introduction
  10.14.4 Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  10.14.5 Pluristem Therapeutics Recent Development and Reaction to COVID-19
13.15 Cyagen
  10.15.1 Cyagen Company Details
  10.15.2 Cyagen Business Overview and Its Total Revenue
  10.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Introduction
  10.15.4 Cyagen Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  10.15.5 Cyagen Recent Development and Reaction to COVID-19
13.16 Lonza
  10.16.1 Lonza Company Details
  10.16.2 Lonza Business Overview and Its Total Revenue
  10.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Introduction
  10.16.4 Lonza Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
  10.16.5 Lonza Recent Development and Reaction to COVID-19

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Adipose Tissue-derived Stem Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Adipose Tissue-derived Stem Cell Therapy Revenue
Table 3. Ranking of Global Top Adipose Tissue-derived Stem Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Autologous Stem Cells
Table 6. Key Players of Allogeneic Stem Cells
Table 7. COVID-19 Impact Global Market: (Four Adipose Tissue-derived Stem Cell Therapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Adipose Tissue-derived Stem Cell Therapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Adipose Tissue-derived Stem Cell Therapy Players to Combat Covid-19 Impact
Table 12. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Regions (2015-2020)
Table 16. Global Adipose Tissue-derived Stem Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Adipose Tissue-derived Stem Cell Therapy Market Growth Strategy
Table 22. Main Points Interviewed from Key Adipose Tissue-derived Stem Cell Therapy Players
Table 23. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Players (2015-2020)
Table 25. Global Top Adipose Tissue-derived Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adipose Tissue-derived Stem Cell Therapy as of 2019)
Table 26. Global Adipose Tissue-derived Stem Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Adipose Tissue-derived Stem Cell Therapy Product Solution and Service
Table 29. Date of Enter into Adipose Tissue-derived Stem Cell Therapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global Adipose Tissue-derived Stem Cell Therapy Market Size Share by Type (2015-2020)
Table 33. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Type (2021-2026)
Table 34. Global Adipose Tissue-derived Stem Cell Therapy Market Size Share by Application (2015-2020)
Table 35. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global Adipose Tissue-derived Stem Cell Therapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players Adipose Tissue-derived Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Adipose Tissue-derived Stem Cell Therapy Market Share (2019-2020)
Table 39. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2015-2020)
Table 41. North America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2015-2020)
Table 43. Europe Key Players Adipose Tissue-derived Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Adipose Tissue-derived Stem Cell Therapy Market Share (2019-2020)
Table 45. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2015-2020)
Table 47. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2015-2020)
Table 49. China Key Players Adipose Tissue-derived Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players Adipose Tissue-derived Stem Cell Therapy Market Share (2019-2020)
Table 51. China Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 52. China Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2015-2020)
Table 53. China Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 54. China Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2015-2020)
Table 55. Japan Key Players Adipose Tissue-derived Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Adipose Tissue-derived Stem Cell Therapy Market Share (2019-2020)
Table 57. Japan Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2015-2020)
Table 59. Japan Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Adipose Tissue-derived Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Adipose Tissue-derived Stem Cell Therapy Market Share (2019-2020)
Table 63. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2015-2020)
Table 65. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2015-2020)
Table 67. India Key Players Adipose Tissue-derived Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players Adipose Tissue-derived Stem Cell Therapy Market Share (2019-2020)
Table 69. India Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 70. India Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2015-2020)
Table 71. India Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 72. India Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Adipose Tissue-derived Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Adipose Tissue-derived Stem Cell Therapy Market Share (2019-2020)
Table 75. Central & South America Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Adipose Tissue-derived Stem Cell Therapy Market Share by Type (2015-2020)
Table 77. Central & South America Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Adipose Tissue-derived Stem Cell Therapy Market Share by Application (2015-2020)
Table 79. AlloCure Company Details
Table 80. AlloCure Business Overview
Table 81. AlloCure Product
Table 82. AlloCure Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 83. AlloCure Recent Development
Table 84. Antria Company Details
Table 85. Antria Business Overview
Table 86. Antria Product
Table 87. Antria Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 88. Antria Recent Development
Table 89. Celgene Corporation Company Details
Table 90. Celgene Corporation Business Overview
Table 91. Celgene Corporation Product
Table 92. Celgene Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 93. Celgene Corporation Recent Development
Table 94. Cellleris Company Details
Table 95. Cellleris Business Overview
Table 96. Cellleris Product
Table 97. Cellleris Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 98. Cellleris Recent Development
Table 99. Corestem Company Details
Table 100. Corestem Business Overview
Table 101. Corestem Product
Table 102. Corestem Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 103. Corestem Recent Development
Table 104. Cytori Therapeutics Company Details
Table 105. Cytori Therapeutics Business Overview
Table 106. Cytori Therapeutics Product
Table 107. Cytori Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 108. Cytori Therapeutics Recent Development
Table 109. Intrexon Company Details
Table 110. Intrexon Business Overview
Table 111. Intrexon Product
Table 112. Intrexon Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 113. Intrexon Recent Development
Table 114. Mesoblast Business Overview
Table 115. Mesoblast Product
Table 116. Mesoblast Company Details
Table 117. Mesoblast Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 118. Mesoblast Recent Development
Table 119. Pluristem Therapeutics Company Details
Table 120. Pluristem Therapeutics Business Overview
Table 121. Pluristem Therapeutics Product
Table 122. Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 123. Pluristem Therapeutics Recent Development
Table 124. Tissue Genesis Company Details
Table 125. Tissue Genesis Business Overview
Table 126. Tissue Genesis Product
Table 127. Tissue Genesis Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 128. Tissue Genesis Recent Development
Table 129. BioRestorative Therapies Company Details
Table 130. BioRestorative Therapies Business Overview
Table 131. BioRestorative Therapies Product
Table 132. BioRestorative Therapies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 133. BioRestorative Therapies Recent Development
Table 134. Celltex Therapeutics Corporation Company Details
Table 135. Celltex Therapeutics Corporation Business Overview
Table 136. Celltex Therapeutics Corporation Product
Table 137. Celltex Therapeutics Corporation Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 138. Celltex Therapeutics Corporation Recent Development
Table 139. iXCells Biotechnologies Company Details
Table 140. iXCells Biotechnologies Business Overview
Table 141. iXCells Biotechnologies Product
Table 142. iXCells Biotechnologies Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 143. iXCells Biotechnologies Recent Development
Table 144. Pluristem Therapeutics Company Details
Table 145. Pluristem Therapeutics Business Overview
Table 146. Pluristem Therapeutics Product
Table 147. Pluristem Therapeutics Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 148. Pluristem Therapeutics Recent Development
Table 149. Cyagen Company Details
Table 150. Cyagen Business Overview
Table 151. Cyagen Product
Table 152. Cyagen Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 153. Cyagen Recent Development
Table 154. Lonza Company Details
Table 155. Lonza Business Overview
Table 156. Lonza Product
Table 157. Lonza Revenue in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020) (Million US$)
Table 158. Lonza Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Autologous Stem Cells Features
Figure 3. Allogeneic Stem Cells Features
Figure 4. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Therapeutic Application Case Studies
Figure 6. Research Application Case Studies
Figure 7. Adipose Tissue-derived Stem Cell Therapy Report Years Considered
Figure 8. Global Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 10. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Adipose Tissue-derived Stem Cell Therapy Market Share by Players in 2019
Figure 13. Global Top Adipose Tissue-derived Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adipose Tissue-derived Stem Cell Therapy as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Adipose Tissue-derived Stem Cell Therapy Revenue in 2019
Figure 15. North America Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Adipose Tissue-derived Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. AlloCure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. AlloCure Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 24. Antria Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Antria Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 26. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Celgene Corporation Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 28. Cellleris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Cellleris Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 30. Corestem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Corestem Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 32. Cytori Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Cytori Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 34. Intrexon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Intrexon Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 36. Mesoblast Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Mesoblast Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 38. Pluristem Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pluristem Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 40. Tissue Genesis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Tissue Genesis Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 42. BioRestorative Therapies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. BioRestorative Therapies Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 44. Celltex Therapeutics Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Celltex Therapeutics Corporation Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 46. iXCells Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. iXCells Biotechnologies Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 48. Pluristem Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Pluristem Therapeutics Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 50. Cyagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Cyagen Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 52. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Lonza Revenue Growth Rate in Adipose Tissue-derived Stem Cell Therapy Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed